Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases. | IBRO Neurosci Rep | 2023 | 36880056 | PubTator, text mining | PubMed |
| Analysis of Conocurvone, Ganoderic acid A and Oleuropein molecules against the main protease molecule of COVID-19 by in silico approaches: Molecular dynamics docking studies. | Eng Anal Bound Elem | 2023 | 36875283 | PubTator, text mining | PubMed |
| SMN post-translational modifications in spinal muscular atrophy. | Front Cell Neurosci | 2023 | 36874214 | PubTator, text mining | PubMed |
| Chemical RNA Cross-Linking: Mechanisms, Computational Analysis, and Biological Applications. | JACS Au | 2023 | 36873678 | PubTator, text mining | PubMed |
| Successful weaning from the invasive respiratory support after nusinersen treatment in a child with SMA type 1: A case report. | Front Pediatr | 2023 | 36873628 | PubTator, text mining | PubMed |
| Longitudinal Assessment of Timed Function Tests in Ambulatory Individuals with SMA Treated with Nusinersen. | J Neuromuscul Dis | 2023 | 36872785 | PubTator, text mining | PubMed |
| Myopathic changes caused by protein aggregates in adult-onset spinal muscular atrophy. | Neuropathology | 2023 | 36864825 | PubTator, text mining | PubMed |
| Remodeling oncogenic transcriptomes by small molecules targeting NONO. | Nat Chem Biol | 2023 | 36864190 | PubTator, text mining | PubMed |
| A spinal muscular atrophy modifier implicates the SMN protein in SNARE complex assembly at neuromuscular synapses. | Neuron | 2023 | 36863345 | PubTator, text mining | PubMed |
| Drug Discovery Perspectives of Antisense Oligonucleotides. | Biomol Ther (Seoul) | 2023 | 36859811 | PubTator, text mining | PubMed |
| Screening and prenatal diagnosis of survival motor neuron gene deletion in pregnant women in Zhaoqing city, Guangdong Province. | BMC Med Genomics | 2023 | 36859245 | PubTator, text mining | PubMed |
| Treatment of spinal muscular atrophy with Onasemnogene Abeparvovec in Switzerland: a prospective observational case series study. | BMC Neurol | 2023 | 36855136 | PubTator, text mining | PubMed |
| Dysfunctional mitochondria accumulate in a skeletal muscle knockout model of Smn1, the causal gene of spinal muscular atrophy. | Cell Death Dis | 2023 | 36849544 | PubTator, text mining | PubMed |
| A multicenter prospective study of next-generation sequencing-based newborn screening for monogenic genetic diseases in China. | World J Pediatr | 2023 | 36847978 | PubTator, text mining | PubMed |
| Longitudinal developmental profile of newborns and toddlers treated for spinal muscular atrophy. | Ther Adv Neurol Disord | 2023 | 36846472 | PubTator, text mining | PubMed |
| Case report: A novel homozygous histidine triad nucleotide-binding protein 1 mutation featuring distal hereditary motor-predominant neuropathy with rimmed vacuoles. | Front Neurol | 2023 | 36846110 | PubTator, text mining | PubMed |
| Research and Therapeutic Approaches in Stem Cell Genome Editing by CRISPR Toolkit. | Molecules | 2023 | 36838970 | PubTator, text mining | PubMed |
| First Use of Non-Invasive Spinal Cord Stimulation in Motor Rehabilitation of Children with Spinal Muscular Atrophy. | Life (Basel) | 2023 | 36836806 | PubTator, text mining | PubMed |
| A Potential Therapy Using Antisense Oligonucleotides to Treat Autosomal Recessive Polycystic Kidney Disease. | J Clin Med | 2023 | 36835961 | PubTator, text mining | PubMed |
| Long-Term SMN- and Ncald-ASO Combinatorial Therapy in SMA Mice and NCALD-ASO Treatment in hiPSC-Derived Motor Neurons Show Protective Effects. | Int J Mol Sci | 2023 | 36835624 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=33